A human/mouse chimeric monoclonal antibody against intercellular adhesion molecule-1 for tumor radioimmunoimaging

Japanese Journal of Cancer Research

Volumn 87, Issue 4, 1996, Pages 405-411

  Yamamura, Miyuki ^a   Hinoda, Yuji ^a   Sasaki, Shigeru ^a   Tsujisaki, Masayuki ^a   Oriuchi, Noboru ^b   Endo, Keigo ^b   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Chimeric monoclonal antibody; ICAM 1; Radioimmunoimaging

Indexed keywords

CHIMERIC ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MONOCLONAL ANTIBODY; TECHNETIUM 99M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EXPRESSION VECTOR; GAMMA SCINTIGRAPHY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOGENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STOMACH CARCINOMA;

EID: 0030029405     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00237.x     Document Type: Article

References (39)

1. Rothlein, R., Dustin, M. L., Marlin, S. D. and Springer, T. A. A human intercellular adhesion molecule-1 (ICAM-1) distinct from LFA-1. J. Immunol., 137, 1270-1274 (1986).
2. Diamond, M. S., Staunton, D. E., Marlin, S. D. and Springer, T. A. Binding of the integrin Mac-1 (CD11b/ CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell, 65, 961-971 (1991).
3. Rosenstein, Y., Park, J. K., Hahn, W. C., Rosen, F. S., Bierer, B. E. and Burakoff, S. J. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature, 354, 233-235 (1991).
4. Miaio, M., Pinto, A., Carbone, A., Zagonel, V., Gloghini, A., Marrota, C., Cirillo, D., Colombatti, A., Ferrara, F., Vecchio, L. D. and Ferrone, S. Differential expression of CD54/intercellular adhesion molecule-1 in lymphoid leukemias and in lymphoproliferative disorder. Blood, 76, 783-790 (1990).
5. Natari, P., Nicotra, M. R., Cavaliere, R., Bigotti, A., Romano, G., Temponi, M. and Ferrone, S. Differential expression of intercellular adhesion molecule-1 in primary and metastatic melanoma lesions. Cancer Res., 50, 1271-1278 (1990).
6. Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A. and Springer, T. A. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol., 137, 245-254 (1986).
7. Pober, J. S., Gimbrone, M. A., Jr., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R. and Springer, T. A. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor, and immune interferon. J. Immunol., 137, 1893-1896 (1986).
8. Tsujisaki, M., Imai, K., Hirata, H., Hanzawa, Y., Masuya, J., Nakano, T., Sugiyama, T., Matsui, M., Hinoda, Y. and Yachi, A. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin. Exp. Immunol., 85, 3-8 (1991).
9. Droz, D., Patey, N., Paraf, F., Chretien, Y. and Gogusev, J. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors. Lab. Invest., 71, 710-719 (1994).
10. Janossy, G., Tidman, N., Papageorgiu, E. S., Kung, P. C. and Goldstein, G. Distribution of T-lymphocyte subsets in the human bone marrow and thymus: an analysis with monoclonal antibodies. J. Immunol., 126, 1608-1613 (1981).
11. Reinherz, E., Kung, P. C., Goldstein, G., Levey, R. H. and Schlossmann, S. F. Discrete stage of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. Natl. Acad. Sci. USA, 77, 1588-1592 (1980).
12. Xiang, J., Roder, J. and Hozumi, N. Production of murine V-human Cγ1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR. Mol. Immunol., 27, 809-817 (1990).
13. 131I-chimeric mouse/human B72.3 (human γ4) monoclonal antibody in humans. Cancer Res., 51, 5461-5466 (1991).
14. Meredith, R. F., Obuglio, A. F., Plott, W. E., Orr, R. A., Brezovich, I. A., Russell, C. D., Harvey, E. B., Yester, M. V., Wagner, A. J., Spencer, S. A., Wheeler, R. H., Saleh, M. N., Rogers, K. J., Polansky, A., Salter, M. M. and Khazaeri, M. B. Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/ human IgG, κ 17-1A monoclonal antibody. J. Nucl. Med., 32, 1162-1168 (1991).
15. Kabat, E. A., Wu, T. T., Reid-Miller, M., Perry, H. M. and Gottesman, K. S. "Sequences of Proteins of Immunological Interest," 4th Ed. (1987). U. S. Dept. Health and Human Services, Washington, D. C.
16. Davis, L. G., Dibner, M. D. and Battey, J. F. Guanidine isothiocyanate preparation of total RNA. In "Basic Methods in Molecular Biology," ed. L. G. Davis, M. D. Dibner and J. F. Battey, pp. 91-96 (1986). Elsevier, New York.
17. Kawasaki, E. S., Innis, M. A., Gelfand, D. H., Sninsky, J. J. and White, T. J. Amplification of RNA. In "PCR Protocols. A Guide to Methods and Applications," ed. M. A. Innis et al., pp. 21-27 (1990). Academic Press Inc., San Diego.
18. Potter, H., Weir, L. and Leder, P. Enhancer-dependent expression of human κ immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA, 81, 7161-7165 (1984).
19. Ey, P. L., Prowes, S. J. and Jenkin, C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry, 15, 429-436 (1978).
20. 131I-labeled human growth hormone of high specific radioactivity. Biochem. J., 89, 114-117 (1963).
21. Mather, S. J. and Ellison, D. Reduction-mediated technetium-99m labeling of monoclonal antibodies. J. Nucl. Med., 31, 692-697 (1990).
22. Scatchard, G. The attraction of proteins for small molecules and ions. Ann. N. Y. Acad. Sci., 51, 660-664 (1949).
23. Ishida, T., Tsujisaki, M., Hinoda, Y., Imai, K. and Yachi, A. Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product. Jpn. J. Cancer Res., 85, 172-178 (1994).
24. Sun, L. K., Curtis, P., Rakowics-Szulczynska, E., Ghrayeb, J., Chang, N., Morrison, S. L. and Koprowsski, H. Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma associated 17-1A. Proc. Natl. Acad. Sci. USA, 84, 214-218 (1987).
25. Lou, A. Y., Robinson, R. R., Hellstrom, K. E., Murray, E. D., Jr., Chang, C. P. and Hellstrom, I. Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc. Natl. Acad. Sci. USA, 84, 3439-3443 (1987).
26. Goodman, G. E., Hellstrom, I., Brodzinsky, L., Nicaise, C., Kulander, B., Hummel, D. and Hellstrom, K. E. Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer. J. Clin. Oncol., 8, 1084-1092 (1990).
27. Goodmann, G. E., Hellstrom, I., Yelton, D. E., Murray, J. L., O'horo, S., Meaker, E. R., Zeigler, L., Palazollo, P., Nicaise, J., Usakewicz, J. and Hellstrom, K. E. Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer. Cancer Immunol. Immunother., 36, 267-273 (1993).
28. Velders, M. P., Litvinov, S. V., Warnaar, S. O., Gorter, A., Fleuren, G. J., Zurawsky, V. R., Jr. and Coney, L. R. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency. Cancer Res., 54, 1753-1759 (1994).
29. Naganuma, H., Kiessling, R., Patarroyo, M., Hansson, M., Handgretinger, R. and Gronberg, A. Increased susceptibility of INF-γ-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells. Int. J. Cancer, 47, 527-532 (1991).
30. Anichini, D., Motarini, R., Alberti, S., Mantovani, A. and Parmiani, G. T Cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cell to autologous CTL-mediated lysis. Int. J. Cancer, 53, 994-1001 (1993).
31. Webb, D. S. A., Mostowski, H. S. and Gerrard, T. L. Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J. Immunol., 146, 3682-3686 (1991).
32. Jonjic, N., Alberti, S., Peri, G., Jilek, P., Anichini, A., Parmiani, G. and Mantovani, A. Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: role of ICAM-1 defined by antibody blocking and gene transfer. Eur. J. Immunol., 22, 2255-2260 (1992).
33. Huag, C. E., Colvin, R. B., Delmonico, F. L., Auchincloss, H., Tolkoffrubin, N., Preffer, F. I., Rothlein, R., Norris, S., Scharaschmidt, L. and Cosimi, A. B. A phase I trial of immunosuppression with anti-ICAM-1(CD54) mAb in renal allograft recipients. Transplantation, 55, 766-773 (1993).
34. Kavanaugh, A. F., Nichols, L. A. and Lipsky, P. E. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1. Arthritis Rheum., 37, 992-999 (1994).
35. Hirano, T., Tomiyoshi, K., Watanabe, N., Tateno, M., Oriuchi, N., Inoue, T. and Endo, K. Technetium-99m-labeled anti-fibrin monoclonal antibody accumulation in an inflammatory focus. J. Nucl. Med., 33, 1181-1182 (1992).
36. Reuland, P., Winker, K. H., Heuchert, T., Ruch, P., Mueller-Schauenburg, W., Weller, S. and Feine, U. Detection of infection in post-operative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes. J. Nucl. Med., 32, 2209-2214 (1991).
37. Sakahara, H., Saga, T., Hosono, M., Endo, K., Nakai, T., Yamamuro, T., Toyama, S. and Konishi, J. Direct labeling of monoclonal antibody with Tc-99m and its biodistribution in mice. J. Nucl. Med., 32, 1099 (1991).
38. Sung, C., Shockley, T. R., Morrison, P. F., Dvorak, H. F., Yarmush, M. L. and Dedrich, R. L. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors. Cancer Res., 52, 377-384 (1992).
39. 123iodine-labeled anti-ICAM-1 monoclonal antibody. Acta Cardiol., 108, 235-243 (1993).